EP 1622455 A4 20091216 - GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF
Title (en)
GEMINI VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF
Title (de)
GEMINI-VITAMIN-D3-VERBINDUNGEN UND VERFAHREN FÜR IHRE VERWENDUNG
Title (fr)
COMPOSES DE LA VITAMINE D3 GEMINI ET METHODES D'UTILISATION DE CES COMPOSES
Publication
Application
Priority
- US 2004013703 W 20040430
- US 46663803 P 20030430
Abstract (en)
[origin: WO2004098522A2] The invention provides Gemini vitamin D3 compounds, methods for using the compounds to treat vitamin D3 associated states and pharmaceutical compositions containing the compounds.
IPC 8 full level
A01N 45/00 (2006.01); A61K 31/593 (2006.01); A61P 9/12 (2006.01); C07C 1/00 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 3/02 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 5/18 (2017.12); A61P 5/40 (2017.12); A61P 7/02 (2017.12); A61P 7/06 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 9/14 (2017.12); A61P 11/00 (2017.12); A61P 13/00 (2017.12); A61P 13/08 (2017.12); A61P 13/10 (2017.12); A61P 13/12 (2017.12); A61P 15/06 (2017.12); A61P 17/00 (2017.12); A61P 17/12 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/04 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07C 401/00 (2013.01); C07B 2200/05 (2013.01)
Citation (search report)
- [A] WO 03028674 A2 20030410 - CEDARS SINAI MEDICAL CENTER [US] & BROWN ALEX J ET AL: "Vitamin D", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 277, no. 2 PART 2, August 1999 (1999-08-01), pages F157 - F175, ISSN: 0002-9513
- [XY] LI Y C ET AL: "1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, vol. 110, no. 2, 1 July 2002 (2002-07-01), pages 229 - 238, XP002300414, ISSN: 0021-9738
- [XY] LI YAN CHUN: "Vitamin D regulation of the renin-angiotensin system", JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS INC, US, vol. 88, no. 2, 1 February 2003 (2003-02-01), pages 327 - 331, XP002525695, ISSN: 0730-2312
- [XY] KRISTAL-BONEH ESTELA ET AL: "Association of calcitriol and blood pressure in normotensive men", HYPERTENSION (DALLAS), vol. 30, no. 5, November 1997 (1997-11-01), pages 1289 - 1294, XP009124963, ISSN: 0194-911X
- [XY] LIND L ET AL: "REDUCTION OF BLOOD PRESSURE BY TREATMENT WITH ALFACALCIDIOL A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE", ACTA MEDICA SCANDINAVICA, vol. 223, no. 3, 1988, pages 211 - 218, XP009124964, ISSN: 0001-6101
- See references of WO 2004098522A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
LT LV
DOCDB simple family (publication)
WO 2004098522 A2 20041118; WO 2004098522 A3 20050203; AU 2004235775 A1 20041118; CA 2524026 A1 20041118; EP 1622455 A2 20060208; EP 1622455 A4 20091216; JP 2006525367 A 20061109
DOCDB simple family (application)
US 2004013703 W 20040430; AU 2004235775 A 20040430; CA 2524026 A 20040430; EP 04751195 A 20040430; JP 2006514246 A 20040430